アンジェスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/06/11 | 2,304 | 2,360 | 2,149 | 2,181 | -89 | -3.9% | 26,148,300 |
2020/06/10 | 2,104 | 2,285 | 2,084 | 2,270 | +135 | +6.3% | 25,877,200 |
2020/06/09 | 2,002 | 2,146 | 1,978 | 2,135 | +114 | +5.6% | 14,713,400 |
2020/06/08 | 1,992 | 2,071 | 1,947 | 2,021 | +5 | +0.2% | 12,368,100 |
2020/06/05 | 2,070 | 2,081 | 2,015 | 2,016 | -67 | -3.2% | 9,392,500 |
2020/06/04 | 2,128 | 2,142 | 2,070 | 2,083 | -41 | -1.9% | 9,969,300 |
2020/06/03 | 2,080 | 2,150 | 2,062 | 2,124 | +24 | +1.1% | 15,434,900 |
2020/06/02 | 1,998 | 2,113 | 1,969 | 2,100 | +45 | +2.2% | 18,104,300 |
2020/06/01 | 2,120 | 2,134 | 2,030 | 2,055 | -59 | -2.8% | 16,471,200 |
2020/05/29 | 2,022 | 2,127 | 2,000 | 2,114 | +131 | +6.6% | 25,036,600 |
2020/05/28 | 2,010 | 2,070 | 1,881 | 1,983 | -87 | -4.2% | 37,179,500 |
2020/05/27 | 2,080 | 2,148 | 1,991 | 2,070 | -66 | -3.1% | 28,838,800 |
2020/05/26 | 2,113 | 2,309 | 1,860 | 2,136 | +203 | +10.5% | 71,547,400 |
2020/05/25 | 1,860 | 1,961 | 1,820 | 1,933 | +153 | +8.6% | 38,374,500 |
2020/05/22 | 1,837 | 1,894 | 1,768 | 1,780 | +22 | +1.3% | 35,971,100 |
2020/05/21 | 1,542 | 1,780 | 1,521 | 1,758 | +193 | +12.3% | 37,776,100 |
2020/05/20 | 1,552 | 1,593 | 1,468 | 1,565 | -39 | -2.4% | 18,031,600 |
2020/05/19 | 1,710 | 1,720 | 1,565 | 1,604 | -25 | -1.5% | 30,348,100 |
2020/05/18 | 1,500 | 1,637 | 1,477 | 1,629 | +200 | +14% | 28,174,800 |
2020/05/15 | 1,400 | 1,442 | 1,362 | 1,429 | +83 | +6.2% | 20,271,300 |
2020/05/14 | 1,370 | 1,408 | 1,323 | 1,346 | -6 | -0.4% | 15,910,100 |
2020/05/13 | 1,258 | 1,429 | 1,253 | 1,352 | +4 | +0.3% | 34,577,800 |
2020/05/12 | 1,469 | 1,520 | 1,320 | 1,348 | -151 | -10.1% | 32,024,200 |
2020/05/11 | 1,600 | 1,649 | 1,200 | 1,499 | -24 | -1.6% | 80,160,300 |
2020/05/08 | 2,223 | 2,455 | 1,523 | 1,523 | -500 | -24.7% | 91,134,600 |
2020/05/07 | 1,783 | 2,023 | 1,716 | 2,023 | +400 | +24.6% | 52,389,200 |
2020/05/01 | 1,599 | 1,680 | 1,486 | 1,623 | +134 | +9% | 62,463,800 |
2020/04/30 | 1,311 | 1,494 | 1,304 | 1,489 | +280 | +23.2% | 72,671,300 |
2020/04/28 | 1,118 | 1,220 | 1,115 | 1,209 | +42 | +3.6% | 37,004,400 |
2020/04/27 | 1,130 | 1,203 | 1,121 | 1,167 | +64 | +5.8% | 38,307,300 |
2020/04/24 | 1,033 | 1,235 | 1,021 | 1,103 | +71 | +6.9% | 76,209,000 |
2020/04/23 | 999 | 1,034 | 970 | 1,032 | +39 | +3.9% | 20,657,000 |
2020/04/22 | 973 | 1,013 | 963 | 993 | +11 | +1.1% | 20,935,300 |
2020/04/21 | 921 | 1,021 | 916 | 982 | +67 | +7.3% | 43,419,200 |
2020/04/20 | 920 | 930 | 904 | 915 | +20 | +2.2% | 11,375,900 |
2020/04/17 | 909 | 924 | 883 | 895 | +5 | +0.6% | 11,135,100 |
2020/04/16 | 876 | 899 | 865 | 890 | -9 | -1% | 12,668,400 |
2020/04/15 | 894 | 929 | 855 | 899 | -9 | -1% | 31,460,400 |
2020/04/14 | 850 | 908 | 838 | 908 | +150 | +19.8% | 37,292,100 |
2020/04/13 | 715 | 761 | 711 | 758 | +29 | +4% | 10,275,200 |
2020/04/10 | 697 | 729 | 694 | 729 | +20 | +2.8% | 6,909,000 |
2020/04/09 | 685 | 709 | 671 | 709 | +12 | +1.7% | 5,339,400 |
2020/04/08 | 710 | 715 | 684 | 697 | -10 | -1.4% | 6,489,100 |
2020/04/07 | 655 | 709 | 645 | 707 | +52 | +7.9% | 6,333,500 |
2020/04/06 | 675 | 683 | 636 | 655 | -35 | -5.1% | 5,963,500 |
2020/04/03 | 731 | 731 | 668 | 690 | -26 | -3.6% | 8,191,100 |
2020/04/02 | 729 | 738 | 707 | 716 | +13 | +1.8% | 8,171,600 |
2020/04/01 | 716 | 734 | 701 | 703 | +12 | +1.7% | 11,399,500 |
2020/03/31 | 705 | 722 | 687 | 691 | -9 | -1.3% | 6,885,800 |
2020/03/30 | 681 | 725 | 681 | 700 | -15 | -2.1% | 7,037,400 |
1201~
1250
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「アンジェス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アンジェス | 6,700円 | +110.0% | - | 0.00% | - | 10.89倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
ダイト | 209,500円 | +4.5% | -33.7% | 3.34% | 20.95倍 | 0.60倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ミズホメディ | 150,400円 | +1.2% | -13.9% | 5.65% | 8.87倍 | 1.65倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
扶桑薬 | 230,200円 | +8.3% | +98.1% | 3.56% | 7.56倍 | 0.52倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
CANBAS | 102,100円 | - | - | 0.00% | - | 6.53倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
市場注目の銘柄
チャート関連のコラム